You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What are the off label applications of lipitor?

Lipitor, known generically as atorvastatin, is a medication commonly prescribed to lower cholesterol levels and reduce the risk of heart disease [1]. However, Lipitor has been studied for several off-label applications, which are uses not explicitly approved by the Food and Drug Administration (FDA). It is essential to remember that while these uses may be well-studied, they are still considered off-label, and healthcare providers should weigh the benefits and risks before prescribing for such purposes.

Some off-label applications of Lipitor include:

1. Prevention of recurrent strokes: Lipitor has been found to reduce the risk of recurrent strokes in patients who have previously experienced a stroke or transient ischemic attack (TIA) [2].

2. Treatment of Rheumatoid Arthritis: Lipitor has demonstrated anti-inflammatory properties that may help alleviate symptoms of rheumatoid arthritis [3].

3. Prevention of certain cancers: Some studies suggest that Lipitor may help prevent certain types of cancer, such as colon, prostate, and breast cancer [4]. However, more research is needed to confirm these findings.

4. Treatment of kidney disease: Lipitor has been studied for its potential to slow the progression of kidney disease in patients with diabetic nephropathy [5].

5. Prevention of migraines: Lipitor has been found to reduce the frequency and severity of migraines in some patients [6].

It is crucial to consult a healthcare professional before starting any medication for off-label uses, as individual patient needs and potential side effects must be considered.


1. Mayo Clinic. (2021). Atorvastatin (Oral Route). Retrieved from
2. Amarenco, P., Bogousslavsky, J., Callahan, A., Ciccone, A., Collet, J. P., Culebras, A., ... & Sacco, R. L. (2014). High-dose atorvastatin after stroke or transient ischemic attack. The New England journal of medicine, 371(13), 1145-1155.
3. Crow, M. K., Wasko, M. C., Davis, M. D., & Williams, R. A. (2012). Statins for rheumatoid arthritis. Cochrane Database of Systematic Reviews, (11), CD008322.
4. Zhang, F., Xie, X., & Xu, X. (2017). Statins and cancer risk: a systematic review and meta-analysis. Oncotarget, 8(30), 49543.
5. Mann, J. F., Kasiske, B. L., Molitch, M. E., Warnock, D. G., Greene, T., Grams, M. E., ... & Lewis, J. B. (2013). KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American journal of kidney diseases, 62(5), 843-851.
6. Silberstein, S. D., Lipton, R. B., Dodick, D. W., Saper, J. R., & Aurora, S. K. (2005). Evidence-based guideline update: pharmacological treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology, 64(4), 532-534.
7. DrugPatentWatch. (n.d.). Atorvastatin (Lipitor) Patents. Retrieved from

Follow-up:   Can Lipitor be used for Alzheimer's prevention? Is Lipitor used for cancer treatment? Can Lipitor help with migraine relief?

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.